Alert! We've detected that your cookie settings are disabled.
In order to achieve an optimal browsing experience, please enable your cookie settings.
For instructions on how to enable your cookie settings:
Click here for cookie settings
Click here for JavaScript settings
THE PHARMACIST'S NEWS SOURCE
Follow Us FB Twitter  Last Update: July 28, 2015
Email Register | Forgot Password
Password Remember me
       

FDA Approves Odomzo for Basal Cell Carcinoma

July 2015

Basal cell carcinoma is among the most common forms of cancer in the United States.
read more

  • FDA Approves Odomzo for Basal Cell Carcinoma

    July 2015

    Basal cell carcinoma is among the most common forms of cancer in the United States.
    read more

  • FDA Approves Specialty Medication, Praluent, for Cholesterol

    July 2015

    heterozygous familial hypercholesterolemia affects more than 600,000 Americans. Many more have cholesterol that is not well controlled.
    read more

  • FDA Grants New Indication for Kyprolis in MM

    July 2015

    MM is the second most common hematologic cancer with nearly 96,000 individuals in the United States having the disease.
    read more

The Most Read Articles From